The pooled fixed-effect estimate demonstrated an RR of 0.87 (95% CI 0.64-1.17), suggesting a 13% relative risk reduction; however, the CI crossed unity, indicating that the overall effect did not reach statistical significance.
← all excerpts
Association Between Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Atrial Fibrillation Adverse Events: A Systematic Review and Meta-Analysis of Randomized Trials.
1
—
—